Aveanna Healthcare (NASDAQ:AVAH) Price Target Cut to $8.00 by Analysts at Truist Financial

Aveanna Healthcare (NASDAQ:AVAH) had its target price dropped by equities research analysts at Truist Financial from $9.00 to $8.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price points to a potential upside of 25.29% from the stock’s current price.

AVAH has been the topic of a number of other reports. Weiss Ratings downgraded Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. BMO Capital Markets cut their price objective on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, March 20th. Barclays cut their price objective on Aveanna Healthcare from $11.00 to $9.50 and set an “overweight” rating on the stock in a research note on Wednesday, March 25th. Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a research note on Friday, March 20th. Finally, Royal Bank Of Canada cut their price objective on Aveanna Healthcare from $11.00 to $9.00 and set a “sector perform” rating on the stock in a research note on Monday, March 23rd. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $10.25.

Aveanna Healthcare Stock Up 2.7%

Shares of AVAH traded up $0.17 during midday trading on Monday, reaching $6.39. 375,070 shares of the stock were exchanged, compared to its average volume of 1,215,460. Aveanna Healthcare has a 12-month low of $3.73 and a 12-month high of $10.32. The firm has a 50 day simple moving average of $7.13 and a 200-day simple moving average of $8.30. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 6.62. The company has a market cap of $1.39 billion, a price-to-earnings ratio of 6.26 and a beta of 2.08.

Insiders Place Their Bets

In other Aveanna Healthcare news, insider Edwin C. Reisz sold 60,769 shares of Aveanna Healthcare stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $438,144.49. Following the transaction, the insider directly owned 1,447,057 shares of the company’s stock, valued at $10,433,280.97. The trade was a 4.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Patrick A. Cunningham sold 18,436 shares of Aveanna Healthcare stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $132,923.56. Following the completion of the transaction, the insider directly owned 337,755 shares in the company, valued at approximately $2,435,213.55. This represents a 5.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 738,957 shares of company stock valued at $5,458,175. Corporate insiders own 7.00% of the company’s stock.

Institutional Trading of Aveanna Healthcare

Institutional investors have recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd boosted its stake in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after buying an additional 2,400 shares in the last quarter. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at $43,000. Oxford Asset Management LLP acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at $64,000. Bayesian Capital Management LP acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at $85,000. Finally, Lion Street Advisors LLC acquired a new stake in Aveanna Healthcare in the 3rd quarter valued at $89,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.